123 related articles for article (PubMed ID: 8114755)
1. Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation.
Palvimo JJ; Kallio PJ; Ikonen T; Mehto M; Jänne OA
Mol Endocrinol; 1993 Nov; 7(11):1399-407. PubMed ID: 8114755
[TBL] [Abstract][Full Text] [Related]
2. Heterodimerization is mainly responsible for the dominant negative activity of amino-terminally truncated rat androgen receptor forms.
Ikonen T; Palvimo JJ; Jänne OA
FEBS Lett; 1998 Jul; 430(3):393-6. PubMed ID: 9688578
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element.
Kallio PJ; Poukka H; Moilanen A; Jänne OA; Palvimo JJ
Mol Endocrinol; 1995 Aug; 9(8):1017-28. PubMed ID: 7476976
[TBL] [Abstract][Full Text] [Related]
4. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
[TBL] [Abstract][Full Text] [Related]
5. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
Zhou ZX; He B; Hall SH; Wilson EM; French FS
Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
[TBL] [Abstract][Full Text] [Related]
6. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.
Jenster G; van der Korput HA; van Vroonhoven C; van der Kwast TH; Trapman J; Brinkmann AO
Mol Endocrinol; 1991 Oct; 5(10):1396-404. PubMed ID: 1775129
[TBL] [Abstract][Full Text] [Related]
7. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin.
Li J; Fu J; Toumazou C; Yoon HG; Wong J
Mol Endocrinol; 2006 Apr; 20(4):776-85. PubMed ID: 16373397
[TBL] [Abstract][Full Text] [Related]
8. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
[TBL] [Abstract][Full Text] [Related]
9. [Identification of a highly conserved domain that suppresses the DNA-binding domain-DNA interactions in the androgen receptor].
Liu GZ; Wang H; Wang ZX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):394-8. PubMed ID: 16190381
[TBL] [Abstract][Full Text] [Related]
10. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
[TBL] [Abstract][Full Text] [Related]
11. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
[TBL] [Abstract][Full Text] [Related]
12. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
Govindan MV
Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
[TBL] [Abstract][Full Text] [Related]
13. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
[TBL] [Abstract][Full Text] [Related]
14. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
Pakdel F; Reese JC; Katzenellenbogen BS
Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation and transient expression of the human androgen receptor.
Gao T; Marcelli M; McPhaul MJ
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):9-20. PubMed ID: 9009233
[TBL] [Abstract][Full Text] [Related]
16. Involvement of three glutamine tracts in human androgen receptor transactivation.
Harada N; Mitani T; Higashimura Y; Yamaji R; Okamoto K; Nakano Y; Inui H
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):77-84. PubMed ID: 19833203
[TBL] [Abstract][Full Text] [Related]
17. Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding.
Brodie J; McEwan IJ
J Mol Endocrinol; 2005 Jun; 34(3):603-15. PubMed ID: 15956332
[TBL] [Abstract][Full Text] [Related]
18. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
Shaffer PL; McDonnell DP; Gewirth DT
Biochemistry; 2005 Feb; 44(7):2678-85. PubMed ID: 15709781
[TBL] [Abstract][Full Text] [Related]
19. Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein.
Chen S; Supakar PC; Vellanoweth RL; Song CS; Chatterjee B; Roy AK
Mol Endocrinol; 1997 Jan; 11(1):3-15. PubMed ID: 8994183
[TBL] [Abstract][Full Text] [Related]
20. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
